Search Results - "Manola, Judith B"

Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer by Fisch, Michael J, Lee, Ju-Whei, Weiss, Matthias, Wagner, Lynne I, Chang, Victor T, Cella, David, Manola, Judith B, Minasian, Lori M, McCaskill-Stevens, Worta, Mendoza, Tito R, Cleeland, Charles S

“…Pain is prevalent among patients with cancer, yet pain management patterns in outpatient oncology are poorly understood. A total of 3,123 ambulatory patients…”
Get full text

Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial by George, Suzanne, Wang, Qian, Heinrich, Michael C, Corless, Christopher L, Zhu, Meijun, Butrynski, James E, Morgan, Jeffrey A, Wagner, Andrew J, Choy, Edwin, Tap, William D, Yap, Jeffrey T, Van den Abbeele, Annick D, Manola, Judith B, Solomon, Sarah M, Fletcher, Jonathan A, von Mehren, Margaret, Demetri, George D

“…Metastatic GI stromal tumor (GIST) is a life-threatening disease with no therapy of proven efficacy after failure of imatinib and sunitinib. Regorafenib is a…”
Get full text

The Telomerase Reverse Transcriptase Regulates Chromatin State and DNA Damage Responses by Masutomi, Kenkichi, Possemato, Richard, Judy M. Y. Wong, Currier, Jennifer L., Tothova, Zuzana, Manola, Judith B., Ganesan, Shridar, Lansdorp, Peter M., Collins, Kathleen, Hahn, William C., Livingston, David M.

“…Constitutive expression of telomerase prevents senescence and crisis by maintaining telomere homeostasis. However, recent evidence suggests that telomerase is…”
Get full text

Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012 by Pang, Herbert H, Wang, Xiaofei, Stinchcombe, Thomas E, Wong, Melisa L, Cheng, Perry, Ganti, Apar Kishor, Sargent, Daniel J, Zhang, Ying, Hu, Chen, Mandrekar, Sumithra J, Redman, Mary W, Manola, Judith B, Schilsky, Richard L, Cohen, Harvey J, Bradley, Jeffrey D, Adjei, Alex A, Gandara, David, Ramalingam, Suresh S, Vokes, Everett E

“…Purpose Under-representation of elderly, women, and racial/ethnic minority patients with cancer in clinical trials is of national concern. The goal of this…”
Get full text

BEST: A Randomized Phase II Study of Vascular Endothelial Growth Factor, RAF Kinase, and Mammalian Target of Rapamycin Combination Targeted Therapy With Bevacizumab, Sorafenib, and Temsirolimus in Advanced Renal Cell Carcinoma--A Trial of the ECOG-ACRIN Cancer Research Group (E2804) by Flaherty, Keith T, Manola, Judith B, Pins, Michael, McDermott, David F, Atkins, Michael B, Dutcher, Janice J, George, Daniel J, Margolin, Kim A, DiPaola, Robert S

“…On the basis of evidence that resistance to vascular endothelial growth factor (VEGF) receptor inhibition is caused by hypoxia-driven residual VEGF and other…”
Get full text

NF-[kappa]B and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma by Gaykalova, Daria A, Manola, Judith B, Ozawa, Hiroyuki, Zizkova, Veronika, Morton, Kathryn, Bishop, Justin A, Sharma, Rajni, Zhang, Chi, Michailidi, Christina, Considine, Michael, Tan, Marietta, Fertig, Elana J, Hennessey, Patrick T, Ahn, Julie, Koch, Wayne M, Westra, William H, Khan, Zubair, Chung, Christine H, Ochs, Michael F, Califano, Joseph A

“…Using high-throughput analyses and the TRANSFAC database, we characterized TF signatures of head and neck squamous cell carcinoma (HNSCC) subgroups by…”
Get full text

NF‐κB and stat3 transcription factor signatures differentiate HPV‐positive and HPV‐negative head and neck squamous cell carcinoma by Gaykalova, Daria A., Manola, Judith B., Ozawa, Hiroyuki, Zizkova, Veronika, Morton, Kathryn, Bishop, Justin A., Sharma, Rajni, Zhang, Chi, Michailidi, Christina, Considine, Michael, Tan, Marietta, Fertig, Elana J., Hennessey, Patrick T., Ahn, Julie, Koch, Wayne M., Westra, William H., Khan, Zubair, Chung, Christine H., Ochs, Michael F., Califano, Joseph A.

“…Using high‐throughput analyses and the TRANSFAC database, we characterized TF signatures of head and neck squamous cell carcinoma (HNSCC) subgroups by…”
Get full text

CT and PET: Early Prognostic Indicators of Response to Imatinib Mesylate in Patients with Gastrointestinal Stromal Tumor by Holdsworth, Clay H, Badawi, Ramsey D, Manola, Judith B, Kijewski, Marie F, Israel, David A, Demetri, George D, Van den Abbeele, Annick D

“…We report results from a pilot study aimed at optimizing the use of CT bidimensional measurements and 18F-FDG PET maximum standardized uptake values…”
Get full text

When bad things happen to good studies by Manola, Judith B, Gray, Robert J

Get full text

A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer by Courtney, Kevin D, Manola, Judith B, Elfiky, Aymen A, Ross, Robert, Oh, William K, Yap, Jeffrey T, Van den Abbeele, Annick D, Ryan, Christopher W, Beer, Tomasz M, Loda, Massimo, Priolo, Carmen, Kantoff, Philip, Taplin, Mary-Ellen

“…Micro-Abstract Activation of the phosphoinositide 3-kinase signaling cascade, often through loss of the phosphatase and tensin homologue deleted on chromosome…”
Get full text

Vandetanib plus chemotherapy for induction followed by vandetanib or placebo as maintenance for patients with advanced non-small-cell lung cancer: a randomized phase 2 PrECOG study (PrE0501) by Aisner, Joseph, Manola, Judith B, Dakhil, Shaker R, Stella, Philip J, Sovak, Mika A, Schiller, Joan H

“…After early reports of vandetanib's efficacy in the induction setting, we evaluated the effect of combination docetaxel, carboplatin, and vandetanib, followed…”
Get more information

Long-Term Outcomes After Function-Sparing Surgery Without Radiotherapy for Soft Tissue Sarcoma of the Extremities and Trunk by BALDINI, E. H, GOLDBERG, J, JENNER, C, MANOLA, J. B, DEMETRI, G. D, FLETCHER, C. D. M, SINGER, S

“…To define the rate of local recurrence (LR) and identify prognostic factors for LR for patients with soft tissue sarcoma (STS) treated with function-sparing…”
Get full text

Plasma Levels of Heat Shock Protein 70 in Patients with Prostate Cancer: A Potential Biomarker for Prostate Cancer by Abe, Miyako, Manola, Judith B., Oh, William K., Parslow, Diane L., George, Daniel J., Austin, Carolyn L., Kantoff, Philip W.

“…Heat shock protein 70 (Hsp70) is a stress-inducible protein that is also known for its inhibitory effects on apoptosis. Increased Hsp70 expression is reported…”
Get full text

Liposarcoma subtypes: identification with computed tomography and ultrasound-guided percutaneous needle biopsy by Nikolaidis, Paul, Silverman, Stuart G, Cibas, Edmund S, Vansonnenberg, Eric, Rybicki, Frank J, Manola, Judith B, Tuncali, Kemal, Karshbaum, Steven H, Singer, Samuel, Fletcher, Christopher D M, Demetri, George D

“…The purpose of the study was to evaluate the feasibility of image-guided percutaneous needle biopsy to enable specific subtype classification of liposarcoma in…”
Get full text

Assessing a Prostate Cancer Brachytherapy Technique Using Early Patient-Reported Symptoms: A Potential Early Indicator for Technology Assessment? by Seo, Pearl H., D'Amico, Anthony V., Clark, Jack A., Kaplan, Irving, Manola, Judith B., Mitchell, Sonya P., Talcott, James A.

“…Brachytherapy for early prostate cancer can cause long-term urinary, bowel, and sexual dysfunction. Modifying technique may mitigate complications, but…”
Get full text

Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CHOP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial by Advani, Ranjana H, Hong, Fangxin, Ganjoo, Kristen N., Manola, Judith B., Swinnen, Lode J., Habermann, Thomas M, Horning, Sandra J

“…Abstract 1671 Poster Board I-697 Bevacizumab (Avastin), a humanized monoclonal antibody directed against vascular endothelial growth factor (VEGF-A), is…”
Get full text

A strategy for developing a graduate program to prepare managers in dietetics by Carey, Mary, Manola, Judith B

“…Dietetics educators face changing needs of the profession, increasing costs of education and scarcity of resources. A framework for marketing an existing…”
Get full text